Articles - portal - LongeCity

Aging Theories: is an 'aging program' a...

Apr 18 2018 05:45 PM | ImmInst in Articles

by Theodore C. Goldsmith

Read story → 1 comments

Newsletter

Apr 08 2018 08:43 PM | ImmInst in LongeCity

The LongeCity newsletter is usually send out on the 8th/18th day of each month to Members and registered forum users.

To subscribe or unsubscribe: Visit this link and check if the box for 'Send me any updates sent by the board administrator' is...

Read story → 1 comments

LongeCity Connect

Apr 01 2018 04:56 PM | caliban in LongeCity

Database of Experts, Advocates and Volunteers
LongeCity has been 'the' forum for information exchange on life extension for over a decade. Over the years, many of the 'who is who' in the scene have visited the site,...

Read story → 0 comments

Antioxidants- relevant for life extension?

Feb 18 2018 11:29 PM | yoik in Articles

by Vit Zemanek

Read story → 0 comments

About

Jan 08 2018 11:16 PM | ImmInst in LongeCity

The LongeCity (Longecity.org/ImmInst.org) is an international, not-for-profit, membership-based organization

Our mission is "to conquer the blight of involuntary death".
To advance this mission, we aim to foster:

...

Read story → 2 comments

Nootropics in human trials (Intro)

Sep 09 2017 12:15 PM | lukas_93 in Articles

by Lukas

Due to further advances in the field of neuropharmacology new possibilities of cognitive self-enhancement emerge.
Some are marketed as ‘smart drugs’, cognitive enhancers or nootropics.

This article aims to provide a brief overview.

Read story → 0 comments

Aging theories: Is there a unifying factor in a...

Aug 20 2017 05:40 PM | ImmInst in Articles

by: Vit Zemanek

- evolutionary approach to the process of senescence
- programmed theories of aging
- error theories of aging

Read story → 1 comments

Geroprotector Review: Rapamycin and other mTOR...

Jul 18 2017 08:59 PM | s123 in Articles

Sven Bulterijs continues his discussion of prominent compounds with potential life extension efficacy by looking not just at rapamycin but also at its target, the mTOR pathway, which has likely a key role in mediating lifespan. ⇒ read the article i...

Read story → 0 comments

Metformin - a geroprotector?

May 19 2017 07:09 PM | s123 in Articles

Sven Bulterijs first discussed the potential utility of anti-diabetic substance metformin six years ago on LongeCity. Now Sven returns to the topic with a comprehensive and thoughtful discussion of the recent findings and further background information...

Read story → 0 comments

Stewards

May 01 2017 12:40 PM | caliban in LongeCity

LongeCity is a membership based organisation. We are guided by our Constitution (Articles of Incorporation and Bylaws) which is drafted in line with relevant stipulations of the Code of Alabama and US law. --We are governed by a Board of Directors. (M...

Read story → 0 comments